- FDA has issued a nationwide recall of certain levothyroxine sodium tablets sold by Major Rugby due to concerns they are subpotent and may not deliver the intended dosage.
- The recall affects 12 different dosages and cartons of levothyroxine sodium tablets, which are used to treat hypothyroidism and reduce the size of enlarged thyroid glands.
- Major Rugby has advised customers to return the affected medications to the place of purchase, although it noted that taking the recalled medication is not likely to cause adverse health effects.
- The recall is classified as a Class II recall, indicating that the products may cause temporary or medically reversible adverse health consequences.
- The recalled pills were shipped out on January 22, 2025 and include various dosages such as 25 mcg, 50 mcg, 75 mcg, and others.
The FDA has announced a nationwide recall of Major Rugby's levothyroxine sodium tablets due to concerns that the medications are subpotent, meaning they contain less active ingredient than intended. This recall affects 12 different dosages of the medication, which is commonly prescribed for hypothyroidism and to reduce the size of enlarged thyroid glands.12345
The recalled tablets were shipped on January 22, 2025, and the FDA has classified this as a Class II recall, indicating that the products may cause temporary or medically reversible adverse health consequences, although the probability of serious adverse effects is remote. Major Rugby has stated that taking the recalled medication is not likely to cause adverse health effects, but they recommend that customers return the affected products to their place of purchase.6789101112
The specific lots involved in the recall include:
25 mcg (0.025 mg), Lot # N02212, Exp. Date 07/2026
50 mcg (0.050 mg), Lot # N02200, Exp. Date 10/2026
75 mcg (0.075 mg), Lot # N02172, Exp. Date 07/2026
88 mcg (0.088 mg), Lot # N02310, Exp. Date 01/2027
112 mcg (0.0112 mg), Lot # N02203, Exp. Date 09/2026
125 mcg (0.0125 mg), Lot # N02266, Exp. Date 11/2026
150 mcg (0.0150 mg), Lot # N02167, Exp. Date 07/2026
The FDA emphasizes that recalls are initiated when products present a risk of injury or are otherwise defective, ensuring consumer safety remains a priority.
“The recall affects 12 different dosages of levothyroxine sodium tablets, which are used to treat hypothyroidism. Major Rugby stated that while the recalled medication is unlikely to cause adverse health effects, customers should return it to the place of purchase.”
NBC 7 San Diego
